Drug intelligence / Profile preview

4-{4-[2-(1A,7A-dimethyl-4-oxy-octahydro-1-oxa-4-aza-cyclopropa[a]naphthalen-4-yl)-acetylamino]-phenylcarbamoyl}-butyric acid

Development stage
Unknown
Modality
Small Molecules
01

Overview

This compound is a synthetic small molecule with the molecular formula C24H33N3O6 and a molecular weight of approximately 459.5 g/mol. It is classified as an alpha amino acid derivative but does not have any approved medical indications or known clinical use. The drug has been listed in chemical and pharmaceutical databases as an experimental compound, but there are no reported mechanisms of action, targets, or therapeutic applications in humans. No information on its pharmacological activity or development status for any disease is available[1][2].

Other names
4-{4-[2-(1A,7A-dimethyl-4-oxy-octahydro-1-oxa-4-aza-cyclopropa[a]naphthalen-4-YL)-acetylamino]-phenylcarbamoyl}-butyric acid

Beyond the preview

Go deeper on 4-{4-[2-(1A,7A-dimethyl-4-oxy-octahydro-1-oxa-4-aza-cyclopropa[a]naphthalen-4-yl)-acetylamino]-phenylcarbamoyl}-butyric acid.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4-{4-[2-(1A,7A-dimethyl-4-oxy-octahydro-1-oxa-4-aza-cyclopropa[a]naphthalen-4-yl)-acetylamino]-phenylcarbamoyl}-butyric acid.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call